{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:56927919",
      "entity_text" : "exenatide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0079" ]
    }
  },
  "verbose_text" : "\" Because of the suspicion that a linear relationship might be present between blood level of exenatide and the corrected electrocardiographic QT interval, the FDA required a new study, leading to a 12- to 18-month delay in U.S. approval while the drug was approved in Europe.",
  "reading_complete" : "2020-07-28T14:05:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:03:26Z",
  "trigger" : "level",
  "evidence" : [ "level of exenatide" ],
  "pmc_id" : "3220840",
  "score" : 0
}